DEXCOM INC — Director's Dealing 2019

Jan 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2019-01-10

Reporting Person: Murphy Patrick Michael (SVP, GC & Chief Compliance Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-10	Common Stock	S	400	$138.75	Disposed	29708	Direct

Footnotes

F1: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 24,998 unvested restricted stock units, 16,817 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 5,681 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 2,500 of which were granted on March 8, 2016 shall vest through March 8, 2019.